Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Site-directed transposon integration in human cells.

Stephen R Yant1, Yong Huang, Bassel Akache

  • 1Department of Pediatrics and Genetics, Stanford University School of Medicine, Stanford, CA 94305-5208, USA.

Nucleic Acids Research
|March 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

lnc122 RNA prevents liver tumorigenesis in MYC-driven liver cancer.

JHEP reports : innovation in hepatology·2026
Same author

Potential effects of endogenous RNA/DNA hybrids on CRISPR-Cas9-mediated homology-directed repair.

Molecular therapy. Nucleic acids·2026
Same author

First-in-human nuclease-free homologous recombination-dependent gene editing in pediatric patients with methylmalonic acidemia: results of a phase 1/2 study.

Gene therapy·2026
Same author

Heterologous vs. homologous vaccine regimens: Sulfated lactosyl archaeol (SLA) archaeosome-adjuvanted SARS-CoV-2 spike protein boost following an mRNA/LNP prime induces robust and balanced immune responses.

Vaccine·2026
Same author

Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defects.

Science translational medicine·2026
Same author

Reprogramming AAV tropism with tumor-associated targeting ligands.

Molecular therapy. Oncology·2025
Same journal

Neurochondrin promotes U5 snRNP maturation by regulating AAR2 release from PRPF8.

Nucleic acids research·2026
Same journal

Elongationless start-stop elements are stress-resilient translation gates that are more repressive than uTranslons.

Nucleic acids research·2026
Same journal

Evolution of the ribosomal exit tunnel through the eyes of the nascent chain.

Nucleic acids research·2026
Same journal

Enhancing the performance and interpretability of epigenetic clocks.

Nucleic acids research·2026
Same journal

FABIAN-variant 2026: improved prediction of the effects of DNA variants on transcription factor binding.

Nucleic acids research·2026
Same journal

Structural and biochemical characterization of Grimontia hollisae thermostable direct hemolysin with DNA reveals first Vibrio hemolysin with nuclease activity.

Nucleic acids research·2026
See all related articles

Researchers engineered Sleeping Beauty (SB) transposase fusion proteins to direct gene transfer vector integration to specific DNA sites. This novel approach shows feasibility for targeted transposon delivery in human cells.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Genomics

Background:

  • The Sleeping Beauty (SB) transposon is a gene transfer vector with non-specific genomic integration.
  • Targeted integration is crucial for enhancing the safety and efficacy of gene therapy vectors.

Purpose of the Study:

  • To engineer SB transposase fusion proteins with DNA-binding domains (DBDs) to achieve site-specific integration.
  • To evaluate the DNA-binding specificity and transposition activity of these novel fusion proteins.
  • To assess the feasibility of directing transposon integration to predetermined DNA sites in human cells.

Main Methods:

  • Construction of fusion proteins linking hyperactive SB transposase (HSB5) with zinc-finger DNA-binding domains (E2C or Gal4).
  • Transposition assays in human cells to assess activity and specificity.

Related Experiment Videos

  • Molecular analyses to confirm DNA-binding and integration site selection.

    • Main Results:

    • N-terminal fusion of DBDs to SB transposase retained DNA-binding specificity and transposition activity.
    • Fusion protein-mediated tethering successfully redirected transposon insertion site selection.
    • Stable integration complex docking showed potential interference with the transposition mechanism.

    Conclusions:

    • Fusion protein engineering enables directed Sleeping Beauty transposon integration.
    • This strategy offers a promising approach for targeted gene delivery and future gene therapy applications.
    • Further optimization is needed to overcome potential integration complex interference.